An arsenal of magnetic nanoparticles; perspectives in the treatment of cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
  Medline CASGoogle Scholar
• 2 Roos WP, Thomas AD, Kaina B. DNA damage and the balance between survival and death in cancer biology. Nat. Rev. Cancer 16(1), 20–33 (2016).
  Medline CASGoogle Scholar
• 3 Prasad V, Fojo T, Brada M. Precision oncology: origins, optimism, and potential. Lancet Oncol. 17(2), e81–e86 (2016).
  MedlineGoogle Scholar
• 4 Grass RN, Athanassiou EK, Stark WJ. Covalently functionalized cobalt nanoparticles as a platform for magnetic separations in organic synthesis. Angew. Chem. Int. Ed. Engl. 46(26), 4909–4912 (2007).
  Medline CASGoogle Scholar
• 5 Bull E, Madani SY, Sheth R, Seifalian A, Green M, Seifalian AM. Stem cell tracking using iron oxide nanoparticles. Int. J. Nanomedicine 9, 1641–1653 (2014).
  Medline CASGoogle Scholar
• 6 Akbarzadeh A, Samiei M, Davaran S. Magnetic nanoparticles: preparation physical properties, and applications in biomedicine. Nanoscale Res. Lett. 7(1), 144–276X-7–144 (2012).
  Google Scholar
• 7 Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P. Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J. Cell Physiol. 219(2), 449–458 (2009).
  Medline CASGoogle Scholar
• 8 Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int. J. Nanomedicine 8, 2521–2532 (2013). •• Seminal paper on the mechanisms of magnetic nanoparticles (MNP)-induced hyperthermia.
  MedlineGoogle Scholar
• 9 Goya GF, Grazú V, Ibarra MR. Magnetic nanoparticles for cancer therapy. Curr. Nanosci. 4, 1–16 (2008).
  CASGoogle Scholar
• 10 Tietze R, Lyer S, Durr S, Alexiou C. Nanoparticles for cancer therapy using magnetic forces. Nanomedicine (Lond.) 7(3), 447–457 (2012).
  CASGoogle Scholar
• 11 Nanoprobes.com. http://www.nanoprobes.com.
  Google Scholar
• 12 Balasubramanian S, Girija AR, Nagaoka Y et al. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int. J. Nanomedicine 9, 437–459 (2014).
  MedlineGoogle Scholar
• 13 Raoof M, Corr SJ, Kaluarachchi WD et al. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy. Nanomedicine 8(7), 1096–1105 (2012).
  Medline CASGoogle Scholar
• 14 Sadhukha T, Wiedmann TS, Panyam J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34(21), 5163–5171 (2013).
  Medline CASGoogle Scholar
• 15 Swain AK, Pradhan L, Bahadur D. Polymer stabilized Fe₃O₄-graphene as an amphiphilic drug carrier for thermo-chemotherapy of cancer. ACS Appl. Mater. Interfaces 7(15), 8013–8022 (2015).
  Medline CASGoogle Scholar
• 16 Yan SY, Chen MM, Fan JG et al. Therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles. Braz J. Med Biol Res. 47(11), 947–959 (2014).
  Medline CASGoogle Scholar
• 17 Pala K, Serwotka A, Jelen F, Jakimowicz P, Otlewski J. Tumour-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles. Int. J. Nanomedicine 9, 67–76 (2014).
  MedlineGoogle Scholar
• 18 Alvarez-Berrios MP, Castillo A, Rinaldi C, Torres-Lugo M. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines. Int. J. Nanomedicine 9, 145–153 (2014).
  MedlineGoogle Scholar
• 19 Rao W, Zhang W, Poventud-Fuentes I et al. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomater. 10(2), 831–842 (2014).
  Medline CASGoogle Scholar
• 20 Sato I, Umemura M, Mitsudo K et al. Hyperthermia generated with ferucarbotran (resovist(R)) in an alternating magnetic field enhances cisplatin-induced apoptosis of cultured human oral cancer cells. J. Physiol. Sci. 64(3), 177–183 (2014).
  Medline CASGoogle Scholar
• 21 Fantechi E, Innocenti C, Zanardelli M et al. A smart platform for hyperthermia application in cancer treatment: cobalt-doped ferrite nanoparticles mineralized in human ferritin cages. ACS Nano 8(5), 4705–4719 (2014).
  Medline CASGoogle Scholar
• 22 Jaiswal MK, Pradhan A, Banerjee R, Bahadur D. Dual pH and temperature stimuli-responsive magnetic nanohydrogels for thermo-chemotherapy. J. Nanosci. Nanotechnol. 14(6), 4082–4089 (2014).
  Medline CASGoogle Scholar
• 23 Mohammad F, Yusof NA. Doxorubicin-loaded magnetic gold nanoshells for a combination therapy of hyperthermia and drug delivery. J. Colloid Interface Sci. 434, 89–97 (2014).
  Medline CASGoogle Scholar
• 24 Tao C, Zhu Y. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia. Dalton Trans. 43(41), 15482–15490 (2014).
  Medline CASGoogle Scholar
• 25 Wani KD, Kadu BS, Mansara P et al. Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF nps) for hyperthermia and drug delivery applications in breast cancer. PLoS ONE 9(9), e107315 (2014).
  MedlineGoogle Scholar
• 26 Yuan G, Yuan Y, Xu K, Luo Q. Biocompatible PEGylated fe₃O₄ nanoparticles as photothermal agents for near-infrared light modulated cancer therapy. Int. J. Mol. Sci. 15(10), 18776–18788 (2014).
  MedlineGoogle Scholar
• 27 Chen CL, Kuo LR, Lee SY et al. Photothermal cancer therapy via femtosecond-laser-excited FePt nanoparticles. Biomaterials 34(4), 1128–1134 (2013).
  MedlineGoogle Scholar
• 28 Hedayati M, Thomas O, Abubaker-Sharif B et al. The effect of cell cluster size on intracellular nanoparticle-mediated hyperthermia: is it possible to treat microscopic tumours? Nanomedicine (Lond). 8(1), 29–41 (2013).
  CASGoogle Scholar
• 29 Clares B, Biedma-Ortiz RA, Saez-Fernandez E et al. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer. Eur J. Pharm Biopharm. 85(3 Pt A), 329–338 (2013).
  Medline CASGoogle Scholar
• 30 Alvarez-Berrios MP, Castillo A, Mendez J, Soto O, Rinaldi C, Torres-Lugo M. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. Int. J. Nanomedicine 8, 1003–1013 (2013).
  Medline CASGoogle Scholar
• 31 Chiang WH, Ho VT, Chen HH et al. Superparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediated MR imaging and multiple cancer therapeutics. Langmuir 29(21), 6434–6443 (2013).
  Medline CASGoogle Scholar
• 32 Zhao L, Huo M, Liu J et al. In vitro investigation on the magnetic thermochemotherapy mediated by magnetic nanoparticles combined with methotrexate for breast cancer treatment. J. Nanosci. Nanotechnol. 13(2), 741–745 (2013).
  Medline CASGoogle Scholar
• 33 Guo Y, Zhang Z, Kim DH et al. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int. J. Nanomedicine 8, 3437–3446 (2013).
  MedlineGoogle Scholar
• 34 Taratula O, Dani RK, Schumann C et al. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. Int. J. Pharm. 458(1), 169–180 (2013).
  Medline CASGoogle Scholar
• 35 Baba D, Seiko Y, Nakanishi T et al. Effect of magnetite nanoparticles on living rate of MCF-7 human breast cancer cells. Colloids Surf. B Biointerfaces 95, 254–257 (2012).
  Medline CASGoogle Scholar
• 36 Huang C, Neoh KG, Xu L, Kang ET, Chiong E. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy. Biomacromolecules 13(8), 2513–2520 (2012).
  Medline CASGoogle Scholar
• 37 Mi Y, Liu X, Zhao J, Ding J, Feng SS. Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials 33(30), 7519–7529 (2012).
  Medline CASGoogle Scholar
• 38 Li Z, Kawashita M, Kudo TA, Kanetaka H. Sol-gel synthesis, characterization, and in vitro compatibility of iron nanoparticle-encapsulating silica microspheres for hyperthermia in cancer therapy. J. Mater. Sci Mater. Med. 23(10), 2461–2469 (2012).
  Medline CASGoogle Scholar
• 39 Estevanato LL, Da Silva JR, Falqueiro AM et al. Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumour treatment: In vitro evaluation of cytotoxicity and magnetohyperthermia efficacy. Int. J. Nanomedicine 7, 5287–5299 (2012).
  Medline CASGoogle Scholar
• 40 Jiang H, Wang C, Guo Z, Wang Z, Liu L. Silver nanocrystals mediated combination therapy of radiation with magnetic hyperthermia on glioma cells. J. Nanosci. Nanotechnol. 12(11), 8276–8281 (2012).
  Medline CASGoogle Scholar
• 41 Yoshida M, Sato M, Yamamoto Y et al. Tumour local chemohyperthermia using docetaxel-embedded magnetoliposomes: interaction of chemotherapy and hyperthermia. J. Gastroenterol Hepatol. 27(2), 406–411 (2012).
  Medline CASGoogle Scholar
• 42 Chang YS, Savitha S, Sadhasivam S, Hsu CK, Lin FH. Fabrication, characterization, and application of greigite nanoparticles for cancer hyperthermia. J. Colloid Interface Sci. 363(1), 314–319 (2011).
  Medline CASGoogle Scholar
• 43 Yuan CY, Tang QS, Zhang DS. Biocompatibility of Mn_0.4Zn_0.6Fe₂O₄ magnetic nanoparticles and their thermotherapy on VX2-carcinoma-induced liver tumors. J. Nanosci. Nanotechnol. 15(1), 74–84 (2015).
  Medline CASGoogle Scholar
• 44 Bai YY, Zheng S, Zhang L et al. Non-invasively evaluating therapeutic response of nanorod-mediated photothermal therapy on tumour angiogenesis. J. Biomed Nanotechnol. 10(11), 3351–3360 (2014).
  Medline CASGoogle Scholar
• 45 Wang P, Xie X, Wang J, Shi Y, Shen N, Huang X. Ultra-small superparamagnetic iron oxide mediated magnetic hyperthermia in treatment of neck lymph node metastasis in rabbit pyriform sinus VX2 carcinoma. Tumour Biol. 36(10), 8035–8040 (2015).
  Medline CASGoogle Scholar
• 46 Kossatz S, Grandke J, Couleaud P et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 17, 66–015–0576–1 (2015).
  MedlineGoogle Scholar
• 47 Wang L, Zhang P, Shi J et al. Radiofrequency-triggered tumour-targeting delivery system for theranostics application. ACS Appl. Mater. Interfaces 7(10), 5736–5747 (2015).
  Medline CASGoogle Scholar
• 48 Yang K, Yang G, Chen L et al. FeS nanoplates as a multifunctional nano-theranostic for magnetic resonance imaging guided photothermal therapy. Biomaterials 38, 1–9 (2015).
  MedlineGoogle Scholar
• 49 Chen Y, Jiang L, Wang R et al. Injectable smart phase-transformation implants for highly efficient in vivo magnetic-hyperthermia regression of tumors. Adv. Mater. 26(44), 7468–7473 (2014).
  Medline CASGoogle Scholar
• 50 Jeon MJ, Ahn CH, Kim H et al. The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model. J. Exp. Clin. Cancer Res. 33, 57–014–0057-x (2014). • One among several papers highlighting the importance of topical/local administration of MNPs for a more specific, less systemic effect.
  MedlineGoogle Scholar
• 51 Hayashi K, Nakamura M, Miki H et al. Magnetically responsive smart nanoparticles for cancer treatment with a combination of magnetic hyperthermia and remote-control drug release. Theranostics 4(8), 834–844 (2014).
  MedlineGoogle Scholar
• 52 Kolosnjaj-Tabi J, Di Corato R, Lartigue L et al. Heat-generating iron oxide nanocubes: subtle “destructurators” of the tumoral microenvironment. ACS Nano 8(5), 4268–4283 (2014).
  Medline CASGoogle Scholar
• 53 Chen EY, Samkoe KS, Hodge S et al. Modulation of hypoxia by magnetic nanoparticle hyperthermia to augment therapeutic index. Adv. Exp. Med Biol. 812, 87–95 (2014).
  Medline CASGoogle Scholar
• 54 Zadnik PL, Molina CA, Sarabia-Estrada R et al. Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease. J. Neurosurg. Spine 20(6), 740–750 (2014).
  MedlineGoogle Scholar
• 55 Petryk AA, Giustini AJ, Gottesman RE, Trembly BS, Hoopes PJ. Comparison of magnetic nanoparticle and microwave hyperthermia cancer treatment methodology and treatment effect in a rodent breast cancer model. Int. J. Hyperthermia 29(8), 819–827 (2013).
  Medline CASGoogle Scholar
• 56 Yi GQ, Gu B, Chen LK. The safety and efficacy of magnetic nano-iron hyperthermia therapy on rat brain glioma. Tumour Biol. 35(3), 2445–2449 (2014).
  Medline CASGoogle Scholar
• 57 Petryk AA, Giustini AJ, Gottesman RE, Kaufman PA, Hoopes PJ. Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment. Int. J. Hyperthermia 29(8), 845–851 (2013).
  Medline CASGoogle Scholar
• 58 Sun H, Xu L, Fan T et al. Targeted hyperthermia after selective embolization with ferromagnetic nanoparticles in a VX2 rabbit liver tumour model. Int. J. Nanomedicine 8, 3795–3804 (2013).
  MedlineGoogle Scholar
• 59 Oliveira TR, Stauffer PR, Lee CT et al. Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int. J. Hyperthermia 29(8), 835–844 (2013).
  MedlineGoogle Scholar
• 60 Hayashi K, Nakamura M, Sakamoto W et al. Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 3(6), 366–376 (2013).
  Medline CASGoogle Scholar
• 61 Shenoi MM, Iltis I, Choi J et al. Nanoparticle delivered vascular disrupting agents (VDAs), use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Mol. Pharm. 10(5), 1683–1694 (2013).
  Medline CASGoogle Scholar
• 62 Bubnovskaya L, Belous A, Solopan A et al. Nanohyperthermia of malignant tumors. II. in vivo tumour heating with manganese perovskite nanoparticles. Exp. Oncol. 34(4), 336–339 (2012). • The pioneering use of manganese perovskite for malignant tumors.
  Medline CASGoogle Scholar
• 63 Jiang PS, Drake P, Cho HJ et al. Tailored nanoparticles for tumour therapy. J. Nanosci. Nanotechnol. 12(6), 5076–5081 (2012).
  Medline CASGoogle Scholar
• 64 Bae KH, Park M, Do MJ et al. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano 6(6), 5266–5273 (2012).
  Medline CASGoogle Scholar
• 65 Zhang Q, Tong J, Chen H et al. A novel magnetic nanoparticle hyperthermia combined with ACMF-dependant drug release by DAMMs injection in VX-2 liver tumors. J. Nanosci. Nanotechnol. 12(1), 127–131 (2012).
  MedlineGoogle Scholar
• 66 Basel MT, Balivada S, Wang H et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int. J. Nanomedicine 7, 297–306 (2012).
  Medline CASGoogle Scholar
• 67 Solopan S, Belous A, Yelenich A et al. Nanohyperthermia of malignant tumors. I. lanthanum-strontium manganite magnetic fluid as potential inducer of tumour hyperthermia. Exp. Oncol. 33(3), 130–135 (2011).
  Medline CASGoogle Scholar
• 68 Li J, Hu Y, Yang J et al. Hyaluronic acid-modified Fe₃O₄@Au core/shell nanostars for multimodal imaging and photothermal therapy of tumors. Biomaterials 38, 10–21 (2015).
  Medline CASGoogle Scholar
• 69 Mannucci S, Ghin L, Conti G et al. Magnetic nanoparticles from magnetospirillum gryphiswaldense increase the efficacy of thermotherapy in a model of colon carcinoma. PLoS ONE 9(10), e108959 (2014).
  MedlineGoogle Scholar
• 70 Xie J, Zhang Y, Yan C et al. High-performance PEGylated mn-zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics. Biomaterials 35(33), 9126–9136 (2014).
  Medline CASGoogle Scholar
• 71 Yin PT, Shah BP, Lee KB. Combined magnetic nanoparticle-based microRNA and hyperthermia therapy to enhance apoptosis in brain cancer cells. Small 10(20), 4106–4112 (2014).
  Medline CASGoogle Scholar
• 72 Zhou Z, Sun Y, Shen J et al. Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. Biomaterials 35(26), 7470–7478 (2014).
  Medline CASGoogle Scholar
• 73 Toraya-Brown S, Sheen MR, Zhang P et al. Local hyperthermia treatment of tumors induces CD8(⁺) T cell-mediated resistance against distal and secondary tumors. Nanomedicine 10(6), 1273–1285 (2014).
  Medline CASGoogle Scholar
• 74 Tian Q, Wang Q, Yao KX et al. Multifunctional polypyrrole@Fe₃O₄ nanoparticles for dual-modal imaging and in vivo photothermal cancer therapy. Small 10(6), 1063–1068 (2014).
  Medline CASGoogle Scholar
• 75 Yoo D, Jeong H, Noh SH, Lee JH, Cheon J. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angew. Chem. Int. Ed. Engl. 52(49), 13047–13051 (2013).
  Medline CASGoogle Scholar
• 76 Tang QS, Chen DZ, Xue WQ et al. Preparation and biodistribution of ¹⁸⁸Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (¹⁸⁸Re-folate-CDDP/HSA MNPs) in vivo. Int. J. Nanomedicine 6, 3077–3085 (2011).
  Medline CASGoogle Scholar
• 77 Rodrigues HF, Mello FM, Branquinho LC, Zufelato N, Silveira-Lacerda EP, Bakuzis AF. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration. Int. J. Hyperthermia 29(8), 752–767 (2013).
  Medline CASGoogle Scholar
• 78 Coughlin AJ, Ananta JS, Deng N, Larina IV, Decuzzi P, West JL. Gadolinium-conjugated gold nanoshells for multimodal diagnostic imaging and photothermal cancer therapy. Small 10(3), 556–565 (2014).
  Medline CASGoogle Scholar
• 79 Chen W, Ayala-Orozco C, Biswal NC et al. Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. Nanomedicine (Lond.) 9(8), 1209–1222 (2014).
  CASGoogle Scholar
• 80 Shen S, Kong F, Guo X et al. CMCTS stabilized Fe₃O₄ particles with extremely low toxicity as highly efficient near-infrared photothermal agents for in vivo tumour ablation. Nanoscale 5(17), 8056–8066 (2013).
  Medline CASGoogle Scholar
• 81 Lin M, Zhang D, Huang J et al. The anti-hepatoma effect of nanosized mn-zn ferrite magnetic fluid hyperthermia associated with radiation in vitro and in vivo. Nanotechnology 24(25), 255101 (2013).
  MedlineGoogle Scholar
• 82 Lin M, Huang J, Zhang J et al. The therapeutic effect of PEI-Mn_0.5Zn_0.5Fe₂O₄ nanoparticles/pEgr1-HSV-TK/GCV associated with radiation and magnet-induced heating on hepatoma. Nanoscale 5(3), 991–1000 (2013).
  Medline CASGoogle Scholar
• 83 Toraya-Brown S, Sheen MR, Baird JR et al. Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. Integr. Biol. (Camb.) 5(1), 159–171 (2013).
  Medline CASGoogle Scholar
• 84 Hu SH, Liao BJ, Chiang CS, Chen PJ, Chen IW, Chen SY. Core-shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs. Adv. Mater. 24(27), 3627–3632 (2012).
  Medline CASGoogle Scholar
• 85 Ren Y, Zhang H, Chen B et al. Multifunctional magnetic Fe₃O₄ nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Int. J. Nanomedicine 7, 2261–2269 (2012).
  Medline CASGoogle Scholar
• 86 Wang L, Zhang J, An Y et al. A study on the thermochemotherapy effect of nanosized As₂O₃/MZF thermosensitive magnetoliposomes on experimental hepatoma in vitro and in vivo. Nanotechnology 22(31), 315102 (2011).
  MedlineGoogle Scholar
• 87 Liu L, Ni F, Zhang J et al. Silver nanocrystals sensitize magnetic-nanoparticle-mediated thermo-induced killing of cancer cells. Acta Biochim Biophys Sin (Shanghai) 43(4), 316–323 (2011).
  Medline CASGoogle Scholar
• 88 Wang L, Dong J, Ouyang W, Wang X, Tang J. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles. Oncol. Rep. 27(3), 719–726 (2012).
  Medline CASGoogle Scholar
• 89 Farooq A, Whitehead D, Azzawi M. Attenuation of endothelial dependent vasodilator responses, induced by dye encapsulated silica NPs, in-vitro. Nanomedicine 9(3), 413–425 (2014).
  CASGoogle Scholar
• 90 Shukur A, Rizvi SB, Whitehead D, Seifalian A, Azzawi M. Altered sensitivity to nitric oxide donors, induced by intravascular infusion of quantum dots, in murine mesenteric arteries. Nanomedicine 9(4), 532–539 (2013).
  Medline CASGoogle Scholar
• 91 Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293(1), 483–496 (2005).
  CASGoogle Scholar
• 92 Tadic M, Kralj S, Jagodic M, Hanzel D, Makovec D. Magnetic properties of novel superparamagnetic iron oxide nanoclusters and their peculiarity under annealing treatment. Appl. Surf. Sci. 322, 255–264 (2014).
  CASGoogle Scholar
• 93 Ahamed M, Alhadlaq HA, Alam J, Khan MA, Ali D, Alarafi S. Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr. Pharm. Des. 19(37), 6681–6690 (2013).
  Medline CASGoogle Scholar
• 94 Mahmoudi M, Hosseinkhani H, Hosseinkhani M et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem. Rev. 11(2), 253–280 (2011).
  Google Scholar
• 95 Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14, 198–206 (2004).
  MedlineGoogle Scholar
• 96 Mok H, Park JW, Park TG. Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjugate Chem. 19, 797–801 (2008).
  Medline CASGoogle Scholar
• 97 Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. Evaluation of iron oxide nanoparticle biocompatibility. Int. J. Nanomedicine 6, 787–794 (2011).
  Medline CASGoogle Scholar
• 98 Lim J, Yeap SP, Che HX, Low SC. Characterization of magnetic nanoparticle by dynamic light scattering. Nanoscale Res. Lett. 8, 381 (2013). • Explains in detail the major imaging modalities available and how each one may yield different results in terms of nanoparticle size.
  MedlineGoogle Scholar
• 99 Oberdöster G, Elder A, Rinderknecht A. Nanoparticles and the brain: cause for concern? J. Nanosci. Nanotechnol. 9(8), 4996–5007 (2009).
  MedlineGoogle Scholar
• 100 Linse S, Cabaleiro-Lago C, Xue W-F et al. Nucleation of protein fibrillation by nanoparticles. Proc. Natl Acad. Sci. USA 104, 8691–8696 (2007).
  Medline CASGoogle Scholar